A Randomized Study to Compare Efficacy Safety and | Clinical Research Studies Listing

A Randomized Study to Compare Efficacy Safety and Tolerability of Macitentan 75mg Versus Macitentan 10mg in Patients with Pulmonary Arterial Hypertension Followed by an Open-label Treatment Period with Macitentan 75mg

Recruiting

18 years - 75 years

All

Phase 3

4 participants needed

1 Location

Brief description of study

TThe research study is being conducted to compare macitentan 75 mg with the approved macitentan 10 mg to see if it is well tolerated, safe and useful for treating patients with pulmonary arterial hypertension (PAH).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Pulmonary Arterial Hypertension,Pulmonary Arterial Hypertension
Age: 18 years - 75 years
Gender: All

Male and Female Age 18-76 pulmonary arterial hypertension (PAH).

Updated on 04 Aug 2024. Study ID: 848813

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

A Randomized Study to Compare Efficacy Safety and Tolerability of Macitentan 75mg Versus Macitentan 10mg in Patients with Pulmonary Arterial Hypertension Followed by an Open-label Treatment Period with Macitentan 75mg

Brief description of study

Eligibility of study

Find a site

Interested in the study